نتائج البحث

Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Experienced (TE) Patients in France.

• Authors : Pialoux, Gilles¹; Marcelin, Anne-Geneviève²; Despiégel, Nicolas³

Subjects: *HIV infections; *THERAPEUTICS; *HIV integrase inhibitorsFRANCE

• Source: PLoS ONE. 12/29/2015, Vol. 10 Issue 12, p1-14. 14p.

تفاصيل العنوان

Dolutegravir in the long term in children and adolescents: frequent virological failure but rare acquired genotypic resistance.

• Authors : Frange, Pierre^1,2,3 ; Blanche, Stephane^3,4; Veber, Florence³

• Source: HIV Medicine. Nov2021, Vol. 22 Issue 10, p958-964. 7p.

تفاصيل العنوان

Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen.

• Authors : Charpentier C; IAME, UMR 1137, INSERM, Université Paris Diderot, Sorbonne Paris Cité, AP-HP, Laboratoire de Virologie, Hôpital Bichat, AP-HP, Paris, France.; Malet I

Subjects: Mutation, Missense* ; Viral Load*; HIV Infections/HIV Infections/HIV Infections/*drug therapy

• Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2018 Apr 01; Vol. 73 (4), pp. 1039-1044.Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

Longitudinal analysis of integrase N155 H variants in heavily treated patients failing raltegravir-based regimens.

• Authors : Nguyen, HL; Charpentier, C; Nguyen, N

Subjects: RALTEGRAVIR; LONGITUDINAL method; POLYMERASE chain reactionFRANCE

• Source: HIV Medicine; Feb2013, Vol. 14 Issue 2, p85-91, 7p, 1 Chart, 1 Graph

تفاصيل العنوان